Resultados de la búsqueda 731-740 of 20344 for Two-phase
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...
... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.
... two future steps: A Long Term Study of Molecular and Structural Imaging in Atypical Alzheimer's Disease. Rochester, Minn. The purpose of this study is to ...
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...
... 2-year progression free survival (PFS) rate as compared to ACNS0122. ... This phase I trial studies the best dose and side ... The purpose of this study is to ...
This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...
... phase 2 dose (RP2D) of APG-2575. Understanding the Relationship Between Benign Breast Tissue, Benign Breast Disease, and Breast Cancer Development.
This phase II trial tests how well turkey tail ... There is previous evidence of significant tumor shrinkage occurring in the 2-month window between diagnosis and ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?